Suspected Distal Femoral Osteosarcoma: Biopsy Planning and Limb Salvage
A 13-year-old boy has 3 months of progressive left distal thigh pain, worse at night, with a warm swollen distal thigh, an 8° flexion contracture of the knee, and a thigh circumference 3 cm greater than the other side. He was treated with 2 weeks of oral antibiotics for presumed infection with no improvement. Radiographs reportedly show a poorly marginated mixed lytic and sclerotic lesion in the distal femoral metaphysis with periosteal reaction and soft-tissue extension; the physis is open. CRP is 12 mg/L, ESR 34 mm/h, alkaline phosphatase 310 U/L, and LDH 520 U/L. His parents ask whether the biopsy can be done next week at the local hospital to save travel.
1. What is your immediate plan, and why is the biopsy location so important?
Read the worked answer
Do not let the local hospital biopsy this lesion. Refer urgently to a sarcoma center.
- The biopsy must be performed at the definitive center, by the surgeon who would perform the resection. The tract is a contaminated path that must be resected en bloc with the tumor; a transverse or badly placed incision, a drain site in the wrong place, or a hematoma tracking into the adductor compartment can convert a straightforward limb salvage into an amputation or a much larger resection.
- Technique: longitudinal incision in line with the planned resection, direct approach avoiding the neurovascular bundle, no entry into the joint, tourniquet without exsanguination, meticulous hemostasis, frozen section to confirm adequacy, and tissue sent fresh for histology, cultures, and banking rather than floated in formalin.
- Staging in parallel: contrast magnetic resonance imaging of the whole femur, computed tomography of the chest, bone scan or PET, baseline echocardiogram, audiogram and renal function for chemotherapy planning.
Explain to the family that two weeks of antibiotics have already delayed diagnosis; a further delay for convenience is acceptable only if the biopsy is done properly.
2. Assuming localized osteosarcoma with an open physis and no neurovascular involvement, how do you choose between limb salvage options and amputation?
Read the worked answer
Neoadjuvant multi-agent chemotherapy first, then reconstruction after restaging. The reconstruction decision is made on the post-chemotherapy magnetic resonance image and the extent of physeal and joint involvement.
- If the physis and articular surface can be spared, an intercalary reconstruction (allograft or intercalary prosthesis) preserves the native knee and gives the best function.
- If the distal femur and joint must be removed, a modular distal femoral endoprosthesis with extensor mechanism reconstruction is standard. At 13 with an open physis he has substantial remaining growth - perhaps 8–12 cm - so plan for an expandable prosthesis or build in lengthening allowance of 1–2 cm. The 8° flexion contracture and quadriceps involvement affect postoperative extension strength and must be discussed.
- Rotationplasty is a strong option when a large leg-length discrepancy is anticipated or when the family prioritizes durable, high-level function over appearance.
- Amputation is chosen for major neurovascular involvement, massive soft-tissue contamination, infection, a pathologic fracture with displacement and hematoma spread, or a poor response with progressive disease. It is not a failure of care - it is a definitive, durable oncologic operation.
Frame the choice around function, growth, and the family's priorities, not around a single "best" operation.
3. The family is frightened by chemotherapy and asks whether surgery alone could suffice. How do you respond?
Read the worked answer
Answer directly and honestly with numbers, then support the decision-making process.
- Surgery alone for localized osteosarcoma historically yields long-term survival on the order of 10–20% because micrometastases are present at diagnosis in most patients; with multi-agent neoadjuvant and adjuvant chemotherapy, survival is roughly 65–70% for localized disease. This is one of the clearest survival benefits in orthopaedic oncology, so the recommendation is not equipoise.
- Acknowledge the fear without softening the data: chemotherapy causes alopecia, myelosuppression, mucositis, cardiac and renal toxicity, hearing loss, and infertility risk. Explain the monitoring, the possibility of sperm banking, and the involvement of a pediatric oncology team.
- Involve the multidisciplinary team and, if needed, a second opinion at another sarcoma center - families often accept a recommendation more readily when it is confirmed independently.
- If they still decline, document the discussion thoroughly, continue to treat the tumor surgically with the best available option, keep the door open to chemotherapy if they change their mind, and provide psychological support. Do not abandon the family, and do not proceed to a non-oncologic intralesional procedure simply because the ideal pathway was refused.